BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22915072)

  • 1. Chemotherapy-related cognitive impairment: does integrating complementary medicine have something to add? Review of the literature.
    Avisar A; River Y; Schiff E; Bar-Sela G; Steiner M; Ben-Arye E
    Breast Cancer Res Treat; 2012 Nov; 136(1):1-7. PubMed ID: 22915072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative oncology: complementary therapies for cancer survivors.
    Wesa K; Gubili J; Cassileth B
    Hematol Oncol Clin North Am; 2008 Apr; 22(2):343-53, viii. PubMed ID: 18395154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Integrating complementary medicine in oncology supportive care: assessment of patients' needs and expectations during chemotherapy].
    Shalom T; Schiff E; Steiner M; Katz M; Ben-Arye E
    Harefuah; 2011 Aug; 150(8):642-5, 689. PubMed ID: 21939114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alleviating gastro-intestinal symptoms and concerns by integrating patient-tailored complementary medicine in supportive cancer care.
    Ben-Arye E; Aharonson ML; Schiff E; Samuels N
    Clin Nutr; 2015 Dec; 34(6):1215-23. PubMed ID: 25556349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpharmacologic complementary therapies in symptom management for breast cancer survivors.
    Blaes AH; Kreitzer MJ; Torkelson C; Haddad T
    Semin Oncol; 2011 Jun; 38(3):394-402. PubMed ID: 21600369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-related cognitive dysfunction: current animal studies and future directions.
    Seigers R; Schagen SB; Van Tellingen O; Dietrich J
    Brain Imaging Behav; 2013 Dec; 7(4):453-9. PubMed ID: 23949877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive effects of chemotherapy: An integrative review.
    Shaw C; Baldwin A; Anderson C
    Eur J Oncol Nurs; 2021 Oct; 54():102042. PubMed ID: 34607177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Deficits in Breast Cancer Survivors After Chemotherapy and Hormonal Therapy.
    Frank JS; Vance DE; Triebel KL; Meneses KM
    J Neurosci Nurs; 2015 Dec; 47(6):302-12. PubMed ID: 26447567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy and cognitive impairment: treatment options.
    Fardell JE; Vardy J; Johnston IN; Winocur G
    Clin Pharmacol Ther; 2011 Sep; 90(3):366-76. PubMed ID: 21814191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention-deficit/hyperactivity disorder and complementary/alternative medicine.
    Sawni A
    Adolesc Med State Art Rev; 2008 Aug; 19(2):313-26, xi. PubMed ID: 18822835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuro-cognitive impairment in breast cancer patients: pharmacological considerations.
    Cheung YT; Chui WK; Chan A
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):99-111. PubMed ID: 22015329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutrition, metabolism, and integrative approaches in cancer survivors.
    Sierpina V; Levine L; McKee J; Campbell C; Lian S; Frenkel M
    Semin Oncol Nurs; 2015 Feb; 31(1):42-52. PubMed ID: 25636394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer-related Cognitive Impairment: Current Knowledge and Future Challenges].
    Tanimukai H
    Seishin Shinkeigaku Zasshi; 2015; 117(8):585-600. PubMed ID: 26642725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoring Balance for People with Cancer Through Integrative Oncology.
    Fulop JA; Grimone A; Victorson D
    Prim Care; 2017 Jun; 44(2):323-335. PubMed ID: 28501232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural correlates of chemotherapy-related cognitive impairment.
    Kaiser J; Bledowski C; Dietrich J
    Cortex; 2014 May; 54():33-50. PubMed ID: 24632463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to understand cognitive changes associated with chemotherapy for non-central nervous system tumors.
    Nelson WL; Suls J
    J Pain Symptom Manage; 2013 Nov; 46(5):707-21. PubMed ID: 23522517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative and complementary therapies for patients with advanced cancer.
    Marchand L
    Ann Palliat Med; 2014 Jul; 3(3):160-71. PubMed ID: 25841693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment.
    Myers JS; Pierce J; Pazdernik T
    Oncol Nurs Forum; 2008 Nov; 35(6):916-20. PubMed ID: 18980922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy-related Cognitive Impairment in Patients with Hodgkin Lymphoma - Pathophysiology and Risk Factors].
    Fayette D; Gahérová Ľ; Móciková H; Marková J; Kozák T; Horáček J
    Klin Onkol; 2017; 30(2):93-99. PubMed ID: 28397504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.